| Back
2006P-0405
CP 1
Volume 1
Citizen Petition
Reference 1 -
Inappropriate Generics Working Group, 4 - Patient safety issues
involving generic prescribing
Reference
16 - Therepeutic Equivalence of Generic Drugs Response to National
Association of Boards of Pharmacy, available at http://www.fda.gov/cder/news/ntiletter.htm
Reference
17 - Therepeutic Equivalence of Generic Drugs Letter to Health
Practitioners, available at http://www.fda.gov/cder/news/nightgenlett.htm
Reference
18 - Letter from Randall W. Lutter, Ph.D. to the Honorable Rick
Perry, June 17, 2005, available at http://www.fda.gov/oc/opacom/hottopics/importdrugs/perry061705.htm
Reference
41 - Testimony before the Advisory Committee for Pharmaceutical
Science, FDA, Rockville, MD. Steve C. Schachter, M.D., September
23, 1999
All other References Published
Material
Top | Back
Page last updated
October 16, 2006
RSC
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |